Chemoinformaics analysis of Heptyl 2-methylbutyrate
| Molecular Weight | 200.322 | nRot | 8 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 15 |
| Exact Molecular Weight | 200.178 | nRing | 0 |
| Solubility: LogS | -4.044 | nHRing | 0 |
| Solubility: LogP | 7.541 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 37.647 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.246 |
| Synth | 3.607 |
| Natural Product Likeliness | 2.051 |
| NR-PPAR-gamma | 0.886 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.988 |
| Pgp-sub | 0.06 |
| HIA | 0.038 |
| CACO-2 | -4.742 |
| MDCK | 0.0000174 |
| BBB | 0.009 |
| PPB | 0.93537 |
| VDSS | 3.07 |
| FU | 0.0766275 |
| CYP1A2-inh | 0.471 |
| CYP1A2-sub | 0.492 |
| CYP2c19-inh | 0.885 |
| CYP2c19-sub | 0.121 |
| CYP2c9-inh | 0.879 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.425 |
| CYP2d6-sub | 0.285 |
| CYP3a4-inh | 0.22 |
| CYP3a4-sub | 0.137 |
| CL | 9.094 |
| T12 | 0.079 |
| hERG | 0.01 |
| Ames | 0.031 |
| ROA | 0.295 |
| SkinSen | 0.44 |
| Carcinogencity | 0.306 |
| EI | 0.03 |
| Respiratory | 0.493 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.6914 |